Enhancing CRISPR deletion via pharmacological delay of DNA-PKcs

CRISPR-Cas9 deletion (CRISPR-del) is the leading approach for eliminating DNA from mammalian cells and underpins a variety of genome-editing applications. Target DNA, defined by a pair of double-strand breaks (DSBs), is removed during nonhomologous end-joining (NHEJ). However, the low efficiency of...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Genome Res
Auteurs principaux: Bosch-Guiteras, Núria, Uroda, Tina, Guillen-Ramirez, Hugo A., Riedo, Rahel, Gazdhar, Amiq, Esposito, Roberta, Pulido-Quetglas, Carlos, Zimmer, Yitzhak, Medová, Michaela, Johnson, Rory
Format: Artigo
Langue:Inglês
Publié: Cold Spring Harbor Laboratory Press 2021
Sujets:
Method
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7919447/
https://ncbi.nlm.nih.gov/pubmed/33574136
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/gr.265736.120
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires